{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:05:40Z","timestamp":1792242340567,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.pharep.2017.04.018","type":"journal-article","created":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T11:45:47Z","timestamp":1493639147000},"page":"1082-1087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Possible anti-depressant effect of efavirenz and pro-depressive-like effect of voriconazole in specified doses in various experimental models of depression in mice"],"prefix":"10.1007","volume":"69","author":[{"given":"Tejal K.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Digvijay G.","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2017.04.018_bib0005","series-title":"Harrison\u2019s principle of internal medicine","first-page":"2553","article-title":"Mental disorders","author":"Victor","year":"2005"},{"key":"10.1016\/j.pharep.2017.04.018_bib0010","series-title":"The World health report: 2001: Mental health: new understanding, new hope","author":"WHO","year":"2001"},{"issue":"2","key":"10.1016\/j.pharep.2017.04.018_bib0015","first-page":"20","article-title":"Clinical issues in long-term treatment with antidepressants","volume":"61","author":"Zajecka","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.pharep.2017.04.018_bib0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1620\/tjem.204.273","article-title":"Relationship between major depression and high serum cholesterol in Japanese men","volume":"204","author":"Nakao","year":"2004","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.pharep.2017.04.018_bib0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jad.2014.01.016","article-title":"The association between serum lipid levels, suicide ideation, and central serotonergic activity in patients with major depressive disorder","volume":"159","author":"Park","year":"2014","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.pharep.2017.04.018_bib0030","first-page":"17","article-title":"Lipid parameters-significance in patients with endogenous depression","volume":"8","author":"Kale","year":"2014","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"10.1016\/j.pharep.2017.04.018_bib0035","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0447.1997.tb09622.x","article-title":"Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers","volume":"95","author":"Maes","year":"1997","journal-title":"Acta Psychiatry Scand"},{"issue":"1","key":"10.1016\/j.pharep.2017.04.018_bib0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0163-7827(01)00020-0","article-title":"Cholesterol interactions with phospholipids in membranes","volume":"41","author":"Ohvo-Rekil\u00e4","year":"2002","journal-title":"Prog Lipid Res"},{"issue":"22","key":"10.1016\/j.pharep.2017.04.018_bib0045","first-page":"1","article-title":"Reduced cholesterol is associated with the depressive-like behavior in rats through modulation of the brain 5-HT1A receptor","volume":"14","author":"Sun","year":"2015","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.pharep.2017.04.018_bib0050","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1146\/annurev.biochem.78.072407.103859","article-title":"Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain","volume":"78","author":"Russell","year":"2009","journal-title":"Ann Rev Biochem"},{"issue":"2","key":"10.1016\/j.pharep.2017.04.018_bib0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pharep.2017.04.018_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/292598","article-title":"Cholesterol: its regulation and role in central nervous system disorders","volume":"2012","author":"Orth","year":"2012","journal-title":"Cholesterol"},{"key":"10.1016\/j.pharep.2017.04.018_bib0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jns.2004.11.036","article-title":"Cholesterol homeostasis failure as a unifying cause of synaptic degeneration","volume":"229\u2013230","author":"Koudinov","year":"2005","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.pharep.2017.04.018_bib0070","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1242\/dmm.010124","article-title":"Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases","volume":"5","author":"Vance","year":"2012","journal-title":"Dis Model Mech"},{"issue":"2","key":"10.1016\/j.pharep.2017.04.018_bib0075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-2007-979528","article-title":"Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity","volume":"30","author":"Muller","year":"1997","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.pharep.2017.04.018_bib0080","first-page":"3529","article-title":"Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice","volume":"289","author":"Mast","year":"2014","journal-title":"J Biochem"},{"issue":"2","key":"10.1016\/j.pharep.2017.04.018_bib0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1194\/jlr.M900174-JLR200","article-title":"The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol \u221224S-hydroxylase in vitro and in vivo","volume":"51","author":"Shafaati","year":"2010","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.pharep.2017.04.018_bib0090","first-page":"610","article-title":"Evaluation of antidepressant-like activity of aqueous and ethanolic extracts of Terminalia bellirica Roxb fruits in mice","volume":"45","author":"Dhingra","year":"2007","journal-title":"Indian J Exp Biol"},{"issue":"12","key":"10.1016\/j.pharep.2017.04.018_bib0095","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1139\/cjpp-2014-0125","article-title":"Alteration in the expression of exon IIC transcripts of brain-derived neurotrophic factor gene by simvastatin in chronic mild stress in mice: a possible link with dopaminergic pathway","volume":"92","author":"Rana","year":"2014","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2017.04.018_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00427414","article-title":"The validity of animal model of depression","volume":"83","author":"Willner","year":"1984","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharep.2017.04.018_bib0105","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pharep.2017.04.018_bib0110","series-title":"Drug discovery and evaluation: pharmacological assay","first-page":"559","year":"2002"},{"issue":"1","key":"10.1016\/j.pharep.2017.04.018_bib0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/0974-8520.141949","article-title":"Dopamine mediated antidepressant effect of Mucuna Pruriens seeds in various experimental models of depression","volume":"35","author":"Rana","year":"2014","journal-title":"Ayu"},{"issue":"2","key":"10.1016\/j.pharep.2017.04.018_bib0120","first-page":"117","article-title":"Experimental methods for evaluation of psychotropic agents in rodents: II \u2013 antidepressants","volume":"37","author":"Bhattacharya","year":"1999","journal-title":"Indian J Exp Biol"},{"issue":"3","key":"10.1016\/j.pharep.2017.04.018_bib0125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"issue":"1\u20133","key":"10.1016\/j.pharep.2017.04.018_bib0130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainresbull.2007.05.004","article-title":"Involvement of dopamine (DA)\/serotonin (5-HT)\/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2\/D3 dopamine receptor agonist","volume":"74","author":"Dhir","year":"2007","journal-title":"Brain Res Bull"},{"issue":"7\u20138","key":"10.1016\/j.pharep.2017.04.018_bib0135","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.phymed.2006.09.007","article-title":"Behavioural and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the chronic mild stress model of depression in mice","volume":"14","author":"Chen","year":"2007","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.pharep.2017.04.018_bib0140","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","article-title":"Enzymatic determination of total serum cholesterol","volume":"20","author":"Allain","year":"1974","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.pharep.2017.04.018_bib0145","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0091-3057(78)90380-5","article-title":"Method for the rapid determination of norepinephrine: dopamine, and serotonin in the same brain region","volume":"8","author":"Jacobowitz","year":"1978","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.pharep.2017.04.018_bib0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00002030-200101050-00011","article-title":"Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients","volume":"15","author":"Marzolini","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.pharep.2017.04.018_bib0155","first-page":"43","article-title":"Update on the optimal use of voriconazole for invasive fungal infections","volume":"4","author":"Lat","year":"2011","journal-title":"Infect Drug Resist"},{"issue":"6","key":"10.1016\/j.pharep.2017.04.018_bib0160","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4088\/JCP.v69n0610","article-title":"Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"24","key":"10.1016\/j.pharep.2017.04.018_bib0165","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1001\/jama.269.24.3107","article-title":"HMG CoA reductase inhibitors and quality of life","volume":"269","author":"Downs","year":"1993","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.pharep.2017.04.018_bib0170","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/oxfordjournals.aje.a117465","article-title":"Plasma lipid levels and psychologic characteristics in men","volume":"141","author":"Freedman","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pharep.2017.04.018_bib0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/00365519609168296","article-title":"Novel pathways for elimination of cholesterol by extrahepatic formation of side-chain oxidized oxysterols","volume":"226","author":"Diczfalusy","year":"1996","journal-title":"Scand J Clin Lab Investig Suppl"},{"issue":"12","key":"10.1016\/j.pharep.2017.04.018_bib0180","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1194\/jlr.M200293-JLR200","article-title":"On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function","volume":"43","author":"Meaney","year":"2002","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.pharep.2017.04.018_bib0185","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1074\/jbc.272.6.3137","article-title":"Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway","volume":"272","author":"Lehmann","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharep.2017.04.018_bib0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF \u2013 a key transducer of antidepressant effects","volume":"102","author":"Bj\u00f6rkholm","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016304212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016304212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:07Z","timestamp":1752611827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2017.04.018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1734114016304212"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2017.04.018","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible anti-depressant effect of efavirenz and pro-depressive-like effect of voriconazole in specified doses in various experimental models of depression in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2017.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}